REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apex Biotechnology Corp. (五鼎生物技术股份有限公司) (Taiwan, China)

Main Activities: Miscellaneous Manufacturing
Full name: Apex Biotechnology Corp. Profile Updated: January 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Apex Biotechnology Corp specializes in pesticide second-generation testing and generates revenue through products and services in the agriculture industry.

Headquarters
No.7,Li-Hsin Rd.V, Hsinchu Science Park
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Apex Biotechnology Corp. (五鼎生物技术股份有限公司) report to view the information.

Website: http://www.apexbio.com.tw

Basic Information
Total Employees:
Purchase the Apex Biotechnology Corp. (五鼎生物技术股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Apex Biotechnology Corp. (五鼎生物技术股份有限公司) report to view the information.
Financial Auditors:
Purchase the Apex Biotechnology Corp. (五鼎生物技术股份有限公司) report to view the information.
Incorporation Date:
December 02, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Vice President
Ownership Details
Purchase this report to view the information.
9.75%
Purchase this report to view the information.
7.36%
Purchase this report to view the information.
2.38%
Purchase this report to view the information.
1.29%
Purchase this report to view the information.
1.27%
Subsidiaries
Omnis Health Llc (United States)
99%
蘇州五鼎生技醫療器械進出口貿易有限公司
96%
Company Performance
Financial values in the chart are available after Apex Biotechnology Corp. (五鼎生物技术股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
7.7%▲
Total operating revenue
7.7%▲
Operating Profit/Loss (EBIT)
71.62%▲
EBITDA
29.34%▲
Net Profit/Loss for the Period
25.93%▲
Total Assets
-1.11%▼
Total Equity
2.08%▲
Operating Profit Margin (ROS)
3.4%▲
Net Profit Margin
1.08%▲
Return on Equity (ROE)
1.18%▲
Debt/Equity
-0.63%▼
Quick Ratio
0.59%▲
Cash Ratio
0.33%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo